Synvolux is based in Groningen, the Netherlands. Its mission is to develop novel, innovative products for unmet medical needs. Its proprietary technology is unique, safe and highly efficacious in delivery of macromolecular compounds. Synvolux’ delivery technology (SAINT™) is based on a set of proprietary, entirely synthetic lipid structures which have demonstrated to be extremely safe and broadly applicable. Marcel H.J. Ruiters was co-inventor of the SAINT technology and co-founder of Synvolux.